Evidence map›Paper›PMID 35739253›Full record

ArticleCell death and differentiation2022

Aberrant activation of p53/p66Shc-mInsc axis increases asymmetric divisions and attenuates proliferation of aged mammary stem cells.

Chiara Priami, Daniela Montariello, Giulia De Michele, Federica Ruscitto, Andrea Polazzi, Simona Ronzoni, Giovanni Bertalot, Giorgio Binelli, Valentina Gambino, Lucilla Luzi and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Chiara Priami *European Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.ORCID 0000-0001-8041-2432
Daniela Montariello *European Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Giulia De MicheleEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Federica RuscittoEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Andrea PolazziEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Simona RonzoniEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Giovanni BertalotEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Giorgio BinelliDepartment of Biotechnology and Life Sciences, University of Insubria, Via Dunant 3, 21100, Varese, Italy.
Valentina GambinoEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Lucilla LuziEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Marina MapelliEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Marco GiorgioEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy.
Enrica MigliaccioEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy. enrica.migliaccio@ieo.it.ORCID 0000-0002-3989-8773
Pier Giuseppe PelicciEuropean Institute of Oncology (IEO) IRCCS, Via Ripamonti 435, 20141, Milan, Italy. piergiuseppe.pelicci@ieo.it.ORCID 0000-0002-5076-2316
Ripamonti · ITUniversity of Milan · ITOspedale Santa Chiara · ITUniversity of Insubria · ITUniversity of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is accompanied by the progressive decline in tissue regenerative capacity and functions of resident stem cells (SCs). Underlying mechanisms, however, remain unclear. Here we show that, during chronological aging, self-renewing mitoses of mammary SCs (MaSCs) are preferentially asymmetric and that their progeny divides less frequently, leading to decreased number of MaSCs and reduced regenerative potential. Underlying mechanisms are investigated in the p66Shc

Indexed as

Mammary Glands, AnimalSrc Homology 2 Domain-Containing, Transforming Protein 1Stem CellsTumor Suppressor Protein p53AnimalsCell ProliferationMiceShc1 protein, mouseSrc Homology 2 Domain-Containing, Transforming Protein 1Tumor Suppressor Protein p53

Identifiers

PMID35739253
PMCPMC9751089
OpenAlexW4283320523

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.